Our News on Newswise

Newswise: DannyWelch.jpg

The "M" Word

Danny Welch, PhD, researcher at The University of Kansas Cancer Center, studies metastasis, which is responsible for more than 90% of cancer-related deaths.
30-Jul-2020 10:25 AM EDT Add to Favorites

Newswise: ChenNEWFacultyAppointment.jpg

Ronald Chen named a Fellow of the American Society for Radiation Oncology

Dr. Chen joins a group of just 19 physicians and medical physicists who are recognized this year for their contributions to the field of radiation oncology.
23-Jul-2020 2:10 PM EDT Add to Favorites

Expanded Efforts, Focused Approach

Physicians and scientists at The University of Kansas Cancer Center are committed to improving lung cancer outcomes in Kansas.
7-Jul-2020 10:20 AM EDT Add to Favorites

Clearing the Air on E-Cigarettes

Researchers at The University of Kansas Cancer Center are studying vaping to better understand its effects on our health, as well as reduce vaping among adolescents.
30-Jun-2020 9:55 AM EDT Add to Favorites

KU Cancer Center pivots to protect patients and trial participants amidst pandemic

The University of Kansas Cancer Center is helping fight the pandemic in numerous ways.
7-May-2020 6:10 PM EDT Add to Favorites

Newswise: ChenNEWFacultyAppointment.jpg

Ronald Chen elected as Fellow to American Society of Clinical Oncology

Ronald Chen, MD, MPH, has been named a Fellow of the American Society of Clinical Oncology (FASCO) in honor of his extraordinary volunteer service, dedication and commitment to ASCO.
28-Apr-2020 9:50 AM EDT Add to Favorites

University of Kansas Medical Center to Participate in Clinical Trial of Hydroxychloroquine in Health Care Workers

KU Medical Center is one of 60 sites across the nation that will be participating in this clinical trial, led by the Duke Clinical Research Institute.
14-Apr-2020 2:05 PM EDT Add to Favorites

Cancer Center Receives Additional $5 Million in Funding from State of Kansas to Support Ongoing Research

The University of Kansas Cancer Center will receive an additional $5 million from the state budget for the KU Cancer Center Research Fund.
31-Mar-2020 5:15 PM EDT Add to Favorites


See All News

Our Experts on Newswise

Triple-Threat

Triple-negative breast cancer expert Dr. Priyanka Sharma discusses latest research and clinical trial efforts.
18-Jul-2018 1:35 PM EDT

Newswise: KlempJennifer2008.jpg

Getting Survivorship Care Planning Off the Page and Into Practice

Jennifer Klemp, PhD, MPH, director of cancer survivorship and an associate professor at The University of Kansas Cancer Center, is interviewed by Oncology Nursing News. In this interview, Klemp offers insights on some of the critical issues that...
31-Oct-2016 9:30 AM EDT

Newswise: JChien_Lawrence.jpg

Rewriting the Book on Chemo-Resistant Cancers with a DNA Library

KU Cancer Center researcher is finding out why ovarian cancer is resistant to certain types of chemo to eventually identify a different drug target.
30-Jun-2015 5:05 PM EDT

See All Experts

Our YouTube Videos

About

The University of Kansas Cancer Center is a world-class, community-based, NCI-designated cancer research and care partnership spanning two states and involving collaboration among researchers, physicians and cancer support professionals. Together, we are working toward a world without cancer. The University of Kansas Cancer Center is transforming cancer research and clinical care by linking our innovative approach to drug discovery, delivery and development to our nationally accredited patient care program. Our partnership includes cancer research and health care professionals associated with the University of Kansas Medical Center and The University of Kansas Hospital in Kansas City, The University of Kansas in Lawrence, the University of Kansas School of Medicine in Wichita, The Stowers Institute for Medical Research and the members of the Midwest Cancer Alliance. Our research programs include Cancer Biology, Cancer Prevention, Cancer Control and Population Health, and Drug Discovery, Delivery and Experimental Therapeutics. Shared resources include Biospecimen, Biostatistics and Informatics, Clinical Research Office and Lead Development and Optimization.

Disease-specific working groups, including both clinicians and basic research investigators, promote collaborative opportunities and the exchange of research ideas. The disease working groups define clinical research priorities respective to their disease specialty with an emphasis on Investigator Initiated Trials (IITs). The cancer center’s current disease working groups include lung, hematology/bone marrow transplant, gastrointestinal, genitor-urinary, head and neck, breast and brain.

Breaking new ground in cancer research requires state-of-the-art facilities. A 82,400-square-foot University of Kansas Clinical Research Center, which opened in January 2012, houses the Phase I clinical trials program. A recently remodeled, 170,000-square-foot Wahl/Hixon research complex, known as The Kansas Masonic Cancer Research Institute, will house 37 cancer-focused researchers. Building a world-class cancer center that is at the forefront of discovery, development and implementation is just the beginning. The legacy of The University of Kansas Cancer Center endures when discoveries made here benefit cancer patients everywhere.

Experts

Contacts

Kay Hawes
Assoc. Dir of News & Media Relations
Health Care

khawes@kumc.edu

913-617-8698

Pauline Horton
Communications Specialist

phorton2@kumc.edu

913-945-6896

Natalie Lutz
Executive Director, Marketing & University Relatio

nlutz3@kumc.edu

913-588-2598

Marilyn Nielsen
Executive Assistant

mnielsen3@kumc.edu

Donna Peck
Assistant Communications Director

dpeck@kumc.edu

913-588-5956

Christine Wilson
Director of Public Relations

cwilson9@kumc.edu

913-945-6017

Twitter

close
4.11462